|Last Price||Today's Change||52-Week Range||Trading Volume|
|57.47||0.21 (+0.37%)||42.87 - 57.65||10.6 million|
Market data as of 4:01PM 03/07/14. Quotes are delayed by at least 15 min.
New 96-Week ACTG Study Results Presented at CROI 2014; First Large Study Comparing ISENTRESS® (raltegravir) Regimen to Two Protease Inhibitor Regimens in Previously Untreated Adults with HIV-1
03/05/2014 12:15 PM ET